Oriola Oyj (LON:0NES)

Market Cap	148.57M
Revenue (ttm)	1.35B
Net Income (ttm)	-4.24M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	0.06 (6.16%)
Ex-Dividend Date	Mar 20, 2024

Volume	13,587
Average Volume	5,882
Open	0.973
Previous Close	0.970
Day's Range	0.965 - 0.976
52-Week Range	0.894 - 1.534
Beta	0.59
RSI	58.85
Earnings Date	Mar 4, 2025

About Oriola Oyj

Oriola Oyj provides healthcare and wellbeing products primarily in Sweden and Finland. It also offers vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products. In addition, it provides pharmaceutical logistics and dose dispensing services. Further, the company engages in the wholesale of traded goods and over-the counter products, and special licensed medicines; and provision of advisory services. The company serves pharmaceutical companies, pharmacies, veterinarians, and hospitals. Oriola Oyj was i...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2006
• Employees: 895
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NES

Financial Performance

In 2023, Oriola Oyj's revenue was 1.50 billion, a decrease of -2.90% compared to the previous year's 1.54 billion. Losses were -20.70 million, 762.5% more than in 2022.

Financial numbers in EUR